What does FASENRA do?

FASENRA is a biologic medication approved to treat hypereosinophilic syndrome (HES). It is designed to target and remove eosinophils, which play a role in HES. The mechanism of action of FASENRA in HES is not fully understood.

What are eosinophils, and how are they related to HES?

Eosinophils are white blood cells, a normal part of our immune system. When you have HES, a rare disorder, your body has too many eosinophils.

Having a high number of eosinophils in the blood can eventually lead to tissue and multiple organ damage as these eosinophils can enter tissues and cause inflammation. HES can affect any organ in the body, including skin, lungs, stomach, GI tract, heart, nerves, joints, blood vessels, and other organs.

FASENRA is the only FDA-approved HES treatment that is

FASENRA is the only FDA-approved HES treatment that is

ONE INJECTION
EVERY 4 WEEKS*

Icon Of a Calendar Representing a FASENRA Injection Schedule For Hypereosinophilic Syndrome Icon Of a Calendar Representing a FASENRA Injection Schedule For Hypereosinophilic Syndrome

*Dosing comparisons do not imply improved efficacy or safety.

Icon Of a Calendar Representing a FASENRA Injection Schedule For Hypereosinophilic Syndrome Icon Of a Calendar Representing a FASENRA Injection Schedule For Hypereosinophilic Syndrome

Administration options include:

Icon Representing a Healthcare Professional Can Administer FASENRA At Their Office Icon Representing a Healthcare Professional Can Administer FASENRA At Their Office

At Your Doctor’s Office

Your healthcare provider can administer FASENRA at their office.

Icon Representing Home Administration Of Treatment For Hypereosinophilic Syndrome (HES) Icon Representing Home Administration Of Treatment For Hypereosinophilic Syndrome (HES)

At Home

If you and your doctor decide that you will self-administer with the FASENRA Pen, you will receive proper training from a healthcare provider.